The Rise of HKbitEX in the Hong Kong Crypto Market 🚀
Hong Kong Digital Asset Ex Limited (HKbitEX) has achieved a significant milestone by securing provisional approval for licenses 1 and 7 under the Virtual Asset Trading Platform (VATP) regime from the Securities and Futures Commission (SFC). This achievement positions HKbitEX as the fourth licensed crypto exchange in Hong Kong and the first digital financial group to obtain full virtual asset licenses in the region.
HKbitEX Granted FVA Licenses
HKbitEX has received approval in principle for Full Virtual Asset Trading Platform Type 1 and Type 7 activities from the SFC, making it the first digital finance group to obtain such licenses under the new regulatory framework.
The approval of Type 1 and Type 7 VATP licenses highlights HKbitEX’s focus on compliance, investor protection, and innovation in the ever-evolving cryptocurrency landscape
- HKbitEX poised to offer automated trading and OTC transactions for popular assets like Bitcoin and Ethereum
- Plans to introduce automated trading for tokenized products, including STOs, upon token listing approval
- Expected to enhance liquidity in the secondary market and provide diverse opportunities for investors
Looking Ahead
Dr. Gao Han, CEO of HKbitEX, is optimistic about the future of digital finance in Hong Kong following the acquisition of the licenses. Regulatory approval for VATP licenses is crucial for boosting investor confidence and driving growth in the digital asset market.
- HKbitEX aims to expand its offerings and services to shape the future of crypto in Hong Kong and beyond
The Future of Crypto in Hong Kong and Beyond 💰
As HKbitEX secures licenses 1 and 7 under the VATP regime, it marks a significant development in the Hong Kong crypto market. With a focus on compliance, innovation, and investor protection, HKbitEX is set to revolutionize the digital asset landscape in the region.
Stay tuned as HKbitEX continues to expand its services and offerings, paving the way for a new era in crypto trading and investment.
By
By
By
By
By